$3 million medicinal cannabis research to benefit cancer patients

The Morrison Government is investing $3 million from the Medical Research Future Fund (MRFF) to examine the benefits of medicinal cannabis for pain, symptom and side effect management for cancer patients.

Since her own battle, Ms Olivia Newton-John has been an advocate for breast cancer awareness and research, and through her personal experience and ongoing efforts has helped shine a light on the benefits associated with medicinal cannabis. 

Overall more than 11,000 patients are estimated to have been approved to access medicinal cannabis products – with the majority approved this year.

There have only been a limited number of well-designed clinical studies on medicinal cannabis, and there is a need to increase the evidence base to support medical professionals to make their decisions.

Given the increase in prescribed medicinal cannabis, the Government has supported the nation’s medicinal cannabis industry, and cut red tape, to help meet demand.

The medicinal cannabis industry has the potential to make a significant contribution to exports, employment and economic growth, particularly in rural and regional areas.

The first licence for an Australian company to grow and harvest medicinal cannabis was granted in March 2017, and we’re now up to 78 licences.

To support further growth in the industry, applicants with Major Project Status will be given priority to receive medicinal cannabis licences through the Office of Drug Control.

Medical research is one of the core elements of the Morrison Government’s $104 billion Long Term National Health Plan.

You may also like PSA strengthens support for Australian pharmacists working in general practice